These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35811220)

  • 21. Glycemic Variability Assessment in Newly Treated Exocrine Pancreatic Insufficiency With Type 1 Diabetes.
    Lewis DM; Shahid A
    J Diabetes Sci Technol; 2024 Mar; 18(2):430-437. PubMed ID: 35787705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The effectiveness of pancreatic enzyme replacement therapy using microencapsulated pancreatin preparations in the correction of nutritional status in patients with chronic pancreatitis: a prospective observational study].
    Bideeva TV; Maev IV; Kucheryavyy YA; Andreev DN; Shah YS; Lobanova EG; Zaborovskiy AV; Levchenko AI
    Ter Arkh; 2020 Jan; 92(1):30-35. PubMed ID: 32598660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Pancreatic Enzyme Replacement Therapy on Body Weight and Nutritional Assessments After Pancreatoduodenectomy in a Randomized Trial.
    Kim H; Yoon YS; Han Y; Kwon W; Kim SW; Han HS; Yoon DS; Park JS; Park SJ; Han SS; Lee SE; Choi SH; Han IW; Kim E; Jang JY
    Clin Gastroenterol Hepatol; 2020 Apr; 18(4):926-934.e4. PubMed ID: 31520730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exocrine Pancreatic Insufficiency Dosing Guidelines for Pancreatic Enzyme Replacement Therapy Vary Widely Across Disease Types.
    Lewis DM; Rieke JG; Almusaylim K; Kanchibhatla A; Blanchette JE; Lewis C
    Dig Dis Sci; 2024 Feb; 69(2):615-633. PubMed ID: 38117426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Malnutrition after pancreatic enzyme replacement therapy in chronic pancreatitis: Risk factors in real world practice.
    Arutla M; Sarkar S; Unnisa M; Sarkar P; Raj MA; Mrudula MR; G D; Pasham S; Jakkampudi A; Prasanna A; Reddy DN; Talukdar R
    Pancreatology; 2021 Jan; 21(1):34-41. PubMed ID: 33303371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The investigation and management of pancreatic exocrine insufficiency: A retrospective cohort study.
    Shandro BM; Ritehnia J; Chen J; Nagarajah R; Poullis A
    Clin Med (Lond); 2020 Nov; 20(6):535-540. PubMed ID: 33199316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlates of Pancreatic Enzyme Replacement Therapy Intake in Adults with Cystic Fibrosis: Results of a Cross-Sectional Study.
    Olsen MF; Kjøller-Svarre MS; Møller G; Katzenstein TL; Nielsen BU; Pressler T; Lewis JI; Mathiesen IH; Mølgaard C; Faurholt-Jepsen D
    Nutrients; 2022 Mar; 14(7):. PubMed ID: 35405943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gut microbiome as a response marker for pancreatic enzyme replacement therapy in a porcine model of exocrine pancreas insufficiency.
    Ritz S; Hahn D; Wami HT; Tegelkamp K; Dobrindt U; Schnekenburger J
    Microb Cell Fact; 2020 Dec; 19(1):221. PubMed ID: 33272255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enzyme replacement in advanced pancreatic cancer: patient perceptions.
    Landers A; McKenzie C; Pitama SG; Brown H
    BMJ Support Palliat Care; 2023 Oct; 13(e1):e122-e128. PubMed ID: 32201370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pancreatic enzyme replacement therapy (PERT) for malabsorption in patients with metastatic pancreatic cancer.
    Landers A; Muircroft W; Brown H
    BMJ Support Palliat Care; 2016 Mar; 6(1):75-9. PubMed ID: 25164613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pancreatic enzyme replacement therapy for people with cystic fibrosis.
    Somaraju URR; Solis-Moya A
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD008227. PubMed ID: 32761612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perioperative management of pancreatic exocrine insufficiency-evidence-based proposal for a paradigm shift in pancreatic surgery.
    Stern L; Schuette M; Goetz MR; Nitschke C; Bardenhagen J; Scognamiglio P; Stüben BO; Calavrezos L; Amin T; Heumann A; Lohse AW; de Heer G; Izbicki JR; Uzunoglu FG
    HPB (Oxford); 2024 Jan; 26(1):117-124. PubMed ID: 37770362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of pancreatic exocrine replacement therapy for patients with unresectable pancreatic cancer in a randomized trial.
    Woo SM; Joo J; Kim SY; Park SJ; Han SS; Kim TH; Koh YH; Chung SH; Kim YH; Moon H; Hong EK; Lee WJ
    Pancreatology; 2016; 16(6):1099-1105. PubMed ID: 27618657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of pancreatic enzyme replacement therapy in chronic pancreatitis: systematic review and meta-analysis.
    de la Iglesia-García D; Huang W; Szatmary P; Baston-Rey I; Gonzalez-Lopez J; Prada-Ramallal G; Mukherjee R; Nunes QM; Domínguez-Muñoz JE; Sutton R;
    Gut; 2017 Aug; 66(8):1354-1355. PubMed ID: 27941156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maldigestion from pancreatic exocrine insufficiency.
    Pongprasobchai S
    J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():99-102. PubMed ID: 24251713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pancreatic exocrine insufficiency after pancreaticoduodenectomy is more prevalent with pancreaticogastrostomy than with pancreaticojejunostomy. A retrospective multicentre observational cohort study.
    Roeyen G; Jansen M; Ruyssinck L; Chapelle T; Vanlander A; Bracke B; Hartman V; Ysebaert D; Berrevoet F
    HPB (Oxford); 2016 Dec; 18(12):1017-1022. PubMed ID: 27726974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patient-reported use of pancreatic enzyme replacement treatment (PERT) in pancreatic cancer in New Zealand and Australia: a cross-sectional survey study.
    Landers A; Brown H; Al Ruheili J; Russell K; McKenzie C; Agar MR; Yenson VM; Clarke K; Windsor J
    Support Care Cancer; 2024 Jun; 32(6):402. PubMed ID: 38831230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectivity of Pancreatic Enzyme Replacement Therapy in Malnourished Children.
    Güven B; Demir Mis M; Karaman K; Şahin Yaşar A
    J Pediatr Gastroenterol Nutr; 2020 Jun; 70(6):e114-e118. PubMed ID: 32443036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pancreatic Enzyme Replacement Therapy in Patients Undergoing First-Line Gemcitabine Plus
    Trestini I; Carbognin L; Peretti U; Sperduti I; Caldart A; Tregnago D; Avancini A; Auriemma A; Orsi G; Pilotto S; Frulloni L; Capurso G; Bria E; Reni M; Tortora G; Milella M
    Front Oncol; 2021; 11():688889. PubMed ID: 34568019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation and management of exocrine pancreatic insufficiency: pearls and pitfalls.
    Ramsey ML; Hart PA; Forsmark CE
    Curr Opin Gastroenterol; 2023 Sep; 39(5):428-435. PubMed ID: 37530731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.